1Walther MM, Keiser HR, Linchan WM. Pheochromocytoma: evaluation diagnosis and treatment[ J]. World J Urol, 1999,17 (1) :35 - 39.
2Park M, Hryniewiez K, Setaro JF. Pheochromocytoma presenting with myocardial infarction, cardiomyopathy, renal failure, pulmo- nary hemorrhage, and cyclic hypotension: case report and review of unusual presentations of pheochromocytoma [ J]. J Clin Hyper- tens (Greenwich), 2009, 11 (2): 74- 80.
3Smita R J, Thomas B, Wolfgang B, et al. Echocardiac features simulating hypertrophic obstructive cardiomyopathy in a patient with pheochromocytoma [ J ]. Clin Res Cardiol, 2009, 98 ( 3 ) : 195 - 198.
4Tanriver Y, Betz MJ, Nibbe L, et al. Sepsis and cardiomyopathy as rare clinical manifestations of pheochromocytoma: two case re- port studies [ J ]. Exp Clin Endocrinol Diabetes, 2010, 118 (10) : 747 - 753.
5Gervais MK, Gagnon A, Henri M, et al. Pheochromocytoma presenting as inverted Takotsubo cardiomyopathy: a case report and review of the literature [ J/OL]. J Cardiovasc Med (Hagers- town), 2010, Epub ahead of print. [ 2013-06-27 ]. http://jour-nals. lww. com/jcardiovascularrnedicine/pages/articleviewer, aspx? year = 9000&issue = O0000&article = 99708&type = abstract.
6Van Vliet PD, Burchell HB, Titus JL. Focal myocarditis associa- ted with pheochromocytoma [ J]. N Engl J Med, 1966, 274 (20) : 1102 -1108.
7Sardesai SH, Mourant A J, Sivathandon Y, et al. Phaeochromocy- toma and catecholamine induced cardiomyopathy presenting as heart failure [J]. Br Heart J, 1990, 63(4) : 234 -237.
8Imperato-McGinley J, Gautier T, Ehlers K, et al. Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma [J]. N Engl J Med, 1987, 316(13): 793- 797.
9Szakacs JE, Mehlman B. Pathologic changes induced by 1-nore- pineprine: quantitative aspects [ J]. Am J Cardiol, 1960, 5: 619 - 627.
10Varma DR, Deng XF. Cardiovascular alphal-adrenoceptor sub- types: functions and signaling [ J ]. Can J Physiol Pharmacol, 2000, 78(4) : 267 -292.
